Brain Behavior and Immunity,
Journal Year:
2024,
Volume and Issue:
120, P. 430 - 438
Published: June 17, 2024
Recent
studies
have
associated
immune
abnormalities
with
dementia.
IL-6
is
a
crucial
cytokine
in
inflammatory
responses,
and
recent
evidence
has
linked
elevated
levels
to
changes
brain
structure
cognitive
decline.
However,
the
connection
between
levels,
cognition,
volumes,
dementia
risk
requires
exploration
large
prospective
cohorts.
BMC Psychiatry,
Journal Year:
2023,
Volume and Issue:
23(1)
Published: Aug. 15, 2023
Complex
immune-brain
interactions
that
affect
neural
development,
survival
and
function
might
have
causal
therapeutic
implications
for
psychiatric
illnesses.
However,
previous
studies
examining
the
association
between
immune
inflammation
schizophrenia
(SCZ)
yielded
inconsistent
findings.Comprehensive
two-sample
Mendelian
randomization
(MR)
analysis
was
performed
to
determine
cell
signatures
SCZ
in
this
study.
Based
on
publicly
available
genetic
data,
we
explored
associations
731
risk.
A
total
of
four
types
(median
fluorescence
intensities
(MFI),
relative
(RC),
absolute
(AC),
morphological
parameters
(MP))
were
included.
Comprehensive
sensitivity
analyses
used
verify
robustness,
heterogeneity,
horizontal
pleiotropy
results.After
FDR
correction,
had
no
statistically
significant
effect
immunophenotypes.
It
worth
mentioning
some
phenotypes
with
unadjusted
low
P-values,
including
FSC-A
NKT
(β
=
0.119,
95%
CI
0.044
~
0.194,
P
0.002),
DN
(CD4-CD8-)
%T
0.131,
0.054
0.208,
9.03
×
10-
4),
SSC-A
lymphocytes
0.136,
0.059
0.213,
5.43
4).
The
IgD
transitional
estimated
0.127
(95%
0.051
0.203,
1.09
3).
also
a
IgD+
%B
0.130,
0.207,
8.69
DP
(CD4+CD8+)
8.05
Furthermore,
immunophenotypes
identified
be
significantly
associated
risk:
naive
CD4+
(OR
0.986,
0.979
0.992,
1.37
5),
HLA
DR
CD14-
CD16-
0.738
0.642
0.849,
2.00
CD33dim
DR+
CD11b-
AC
0.631,
0.529
0.753,
3.40
7)
activated
&
resting
Treg
%
CD4
0.937,
0.906
0.970,
1.96
4).Our
study
has
demonstrated
close
connection
cells
by
means,
thus
providing
guidance
future
clinical
research.
World Psychiatry,
Journal Year:
2023,
Volume and Issue:
22(1), P. 4 - 24
Published: Jan. 14, 2023
Psychiatric
genetics
has
made
substantial
progress
in
the
last
decade,
providing
new
insights
into
genetic
etiology
of
psychiatric
disorders,
and
paving
way
for
precision
psychiatry,
which
individual
profiles
may
be
used
to
personalize
risk
assessment
inform
clinical
decision‐making.
Long
recognized
heritable,
recent
evidence
shows
that
disorders
are
influenced
by
thousands
variants
acting
together.
Most
these
commonly
occurring,
meaning
every
a
each
disorder,
from
low
high.
A
series
large‐scale
studies
have
discovered
an
increasing
number
common
rare
robustly
associated
with
major
disorders.
The
most
convincing
biological
interpretation
findings
implicates
altered
synaptic
function
autism
spectrum
disorder
schizophrenia.
However,
mechanistic
understanding
is
still
incomplete.
In
line
their
extensive
epidemiological
overlap,
appear
exist
on
continua
share
large
degree
one
another.
This
provides
further
support
notion
current
diagnoses
do
not
represent
distinct
pathogenic
entities,
ongoing
attempts
reconceptualize
nosology.
also
influences
range
behavioral
somatic
traits
diseases,
including
brain
structures,
cognitive
function,
immunological
phenotypes
cardiovascular
disease,
suggesting
shared
potential
importance.
Current
polygenic
score
tools,
predict
susceptibility
illness,
yet
provide
clinically
actionable
information.
likely
improve
coming
years,
they
eventually
become
part
practice,
stressing
need
educate
clinicians
patients
about
use
misuse.
review
discusses
key
possible
applications,
suggests
future
directions.
Nature Communications,
Journal Year:
2024,
Volume and Issue:
15(1)
Published: May 23, 2024
Abstract
Cross-sectional
studies
have
demonstrated
strong
associations
between
physical
frailty
and
depression.
However,
the
evidence
from
prospective
is
limited.
Here,
we
analyze
data
of
352,277
participants
UK
Biobank
with
12.25-year
follow-up.
Compared
non-frail
individuals,
pre-frail
frail
individuals
increased
risk
for
incident
depression
independent
many
putative
confounds.
Altogether,
account
20.58%
13.16%
cases
by
population
attributable
fraction
analyses.
Higher
risks
are
observed
in
males
younger
than
65
years
their
counterparts.
Mendelian
randomization
analyses
support
a
potential
causal
effect
on
Associations
also
inflammatory
markers,
brain
volumes,
Moreover,
these
regional
volumes
three
markers—C-reactive
protein,
neutrophils,
leukocytes—significantly
mediate
Given
scarcity
curative
treatment
high
disease
burden,
identifying
modifiable
factors
depression,
such
as
frailty,
needed.
Molecular Neurobiology,
Journal Year:
2022,
Volume and Issue:
59(10), P. 6460 - 6501
Published: Aug. 13, 2022
Abstract
Evidence
from
clinical,
preclinical,
and
post-mortem
studies
supports
the
inflammatory/immune
hypothesis
of
schizophrenia
pathogenesis.
Less
evident
is
link
between
inflammatory
background
two
well-recognized
functional
structural
findings
pathophysiology:
dopamine-glutamate
aberrant
interaction
alteration
dendritic
spines
architecture,
both
believed
to
be
“quantal”
elements
cortical-subcortical
dysfunctional
network.
In
this
systematic
review,
we
tried
capture
major
linking
inflammation,
glutamate-dopamine
interaction,
post-synaptic
changes
under
a
direct
inverse
translational
perspective,
paramount
picture
that
at
present
lacking.
The
effects
on
dopaminergic
function
appear
bidirectional:
inflammation
influences
dopamine
release,
acts
as
regulator
discrete
processes
involved
in
such
dysregulated
interleukin
kynurenine
pathways.
Furthermore,
glutamate
strongly
supported
by
clinical
aimed
exploring
overactive
microglia
patients
maternal
immune
activation
models,
indicating
impaired
regulation
reduced
N-methyl-D-aspartate
receptor
(NMDAR)
function.
addition,
an
inflammatory/immune-induced
density
scaffold
proteins,
crucial
for
downstream
NMDAR
signaling
synaptic
efficacy,
has
been
demonstrated.
According
these
findings,
significant
increase
plasma
markers
found
compared
healthy
controls,
associated
with
cortical
integrity
connectivity,
relevant
cognitive
deficit
schizophrenia.
Finally,
altered
responses
raises
questions
regarding
potential
new
therapeutic
strategies
specifically
those
forms
are
resistant
canonical
antipsychotics
or
unresponsive
clozapine.
International Journal of Molecular Sciences,
Journal Year:
2023,
Volume and Issue:
24(3), P. 2703 - 2703
Published: Jan. 31, 2023
Autism
spectrum
disorder
(ASD)
is
a
heterogeneous
collection
of
neurodevelopmental
disorders,
difficult
to
diagnose
and
currently
lacking
treatment
options.
The
possibility
finding
reliable
biomarkers
useful
for
early
identification
would
offer
the
opportunity
intervene
with
strategies
improve
life
quality
ASD
patients.
To
date,
there
are
many
recognized
risk
factors
development
ASD,
both
genetic
non-genetic.
Although
epigenetic
may
play
critical
role,
extent
their
contribution
still
under
study.
On
other
hand,
non-genetic
include
pollution,
nutrition,
infection,
psychological
states,
lifestyle,
all
together
known
as
exposome,
which
impacts
mother’s
fetus’s
life,
especially
during
pregnancy.
Pathogenic
non-pathogenic
maternal
immune
activation
(MIA)
autoimmune
diseases
can
cause
various
alterations
in
fetal
environment,
also
contributing
etiology
offspring.
Activation
monocytes,
macrophages,
mast
cells
microglia
high
production
pro-inflammatory
cytokines
indeed
neuroinflammation,
latter
involved
ASD’s
onset
development.
In
this
review,
we
focused
on
factors,
connection
between
inflammation,
macrophage
polarization
syndrome,
MIA,
involvement
microglia.
Brain Behavior and Immunity,
Journal Year:
2023,
Volume and Issue:
113, P. 166 - 175
Published: July 8, 2023
Immune
system
dysfunction
is
hypothesised
to
contribute
structural
brain
changes
through
aberrant
synaptic
pruning
in
schizophrenia.
However,
evidence
mixed
and
there
a
lack
of
inflammation
its
effect
on
grey
matter
volume
(GMV)
patients.
We
that
inflammatory
subgroups
can
be
identified
the
will
show
distinct
neuroanatomical
neurocognitive
profiles.
The
total
sample
consisted
1067
participants
(chronic
patients
with
schizophrenia
n
=
467
healthy
controls
(HCs)
600)
from
Australia
Schizophrenia
Research
Bank
(ASRB)
dataset,
together
218
recent-onset
external
Benefit
Minocycline
Negative
Symptoms
Psychosis:
Extent
Mechanism
(BeneMin)
dataset.
HYDRA
(HeterogeneitY
DiscRiminant
Analysis)
was
used
separate
HC
define
disease-related
based
markers.
Voxel-based
morphometry
inferential
statistics
were
explore
GMV
alterations
deficits
these
subgroups.
An
optimal
clustering
solution
revealed
five
main
groups
separable
HC:
Low
Inflammation,
Elevated
CRP,
IL-6/IL-8,
IFN-γ,
IL-10
an
adjusted
Rand
index
0.573.
When
compared
controls,
IL-6/IL-8
cluster
showed
most
widespread,
including
anterior
cingulate,
reduction.
IFN-γ
least
reduction
impairment
cognitive
performance.
CRP
Inflammation
clusters
dominated
younger
may
not
merely
case
low
vs
high,
but
rather
are
pluripotent,
heterogeneous
mechanisms
at
play
which
could
reliably
accessible,
peripheral
measures.
This
inform
successful
development
targeted
interventions.
Journal of Personalized Medicine,
Journal Year:
2024,
Volume and Issue:
14(4), P. 391 - 391
Published: April 6, 2024
The
prevalence
of
schizophrenia,
affecting
approximately
1%
the
global
population,
underscores
urgency
for
innovative
therapeutic
strategies.
Recent
insights
into
role
neuroinflammation,
gut–brain
axis,
and
microbiota
in
schizophrenia
pathogenesis
have
paved
way
exploration
psychobiotics
as
a
novel
treatment
avenue.
These
interventions,
targeting
gut
microbiome,
offer
promising
approach
to
ameliorating
psychiatric
symptoms.
Furthermore,
advancements
artificial
intelligence
nanotechnology
are
set
revolutionize
psychobiotic
development
application,
enhance
their
production,
precision,
effectiveness.
This
interdisciplinary
heralds
new
era
management,
potentially
transforming
patient
outcomes
offering
beacon
hope
those
afflicted
by
this
complex
disorder.